Hypertension Diagnostics, Inc. (HDII)

Hypertension Diagnostics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2018	FY 2017	FY 2016	FY 2012	FY 2011
Period Ending	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Jun 30, 2012	Jun 30, 2011
Revenue	3.79	3.68	3.57	3.16	-
Revenue Growth (YoY)	3.11%	3.10%	12.96%	-	-
Cost of Revenue	2.84	2.93	3.02	3.27	-
Gross Profit	0.95	0.75	0.55	-0.11	-
Selling, General & Admin	0.92	0.97	1.02	1.19	0.33
Other Operating Expenses	-	-	-	0.05	0.03
Operating Expenses	0.95	1	1.05	1.24	0.36
Operating Income	0	-0.24	-0.5	-1.36	-0.36
Interest Expense	-0.16	-0.16	-0.16	-0.14	-
Interest & Investment Income	0.03	0.03	0.03	0.02	0.01
Other Non Operating Income (Expenses)	0.01	0.01	0.01	0	-0
EBT Excluding Unusual Items	-0.13	-0.37	-0.62	-1.47	-0.36
Pretax Income	-0.13	-0.37	-0.62	-1.47	-0.36
Earnings From Continuing Operations	-0.13	-0.37	-0.62	-1.47	-0.36
Earnings From Discontinued Operations	-	-	-	0.21	0.76
Net Income	-0.13	-0.37	-0.62	-1.26	0.41
Net Income to Common	-0.13	-0.37	-0.62	-1.26	0.41
Shares Outstanding (Basic)	52	52	52	47	43
Shares Outstanding (Diluted)	52	52	52	54	50
Shares Change (YoY)	-	-	-3.26%	8.34%	21.09%
EPS (Basic)	-0.00	-0.01	-0.01	-0.03	0.01
EPS (Diluted)	-0.00	-0.01	-0.01	-0.03	0.01
Free Cash Flow	-0.39	-0.09	-0.39	-1.86	-0.2
Free Cash Flow Per Share	-0.01	-0.00	-0.01	-0.03	-0.00
Gross Margin	25.17%	20.46%	15.45%	-3.54%	-
Operating Margin	0.02%	-6.66%	-14.03%	-42.95%	-
Profit Margin	-3.31%	-10.02%	-17.43%	-40.01%	-
Free Cash Flow Margin	-10.32%	-2.39%	-10.85%	-58.78%	-
EBITDA	0.04	-0.21	-0.47	-1.25	-0.36
EBITDA Margin	0.97%	-5.81%	-13.06%	-39.56%	-
D&A For EBITDA	0.04	0.03	0.03	0.11	0
EBIT	0	-0.24	-0.5	-1.36	-0.36
EBIT Margin	0.02%	-6.66%	-14.03%	-42.95%	-
Revenue as Reported	3.79	3.68	3.57	3.16	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.